✦ LIBER ✦

Eculizumab for paroxysmal nocturnal hemoglobinuria

✍ Scribed by Jame Abraham

Book ID: 118628158
Publisher: Frontline Medical Communications, Inc.
Year: 2008
Tongue: English
Weight: 96 KB
Volume: 5
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(11)70432-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Life-threatening desquamating rash and h

Life-threatening desquamating rash and hyperammonemia following administration of eculizumab for paroxysmal nocturnal hemoglobinuria

✍ Bettina M. Knoll; Louis Letendre; David P. Steensma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 1 views

Extravascular hemolytic attack after ecu

Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria

✍ Tomita, Akihiro; Shirasugi, Yukari; Ito, Takahiko; Tsurumi, Hisashi; Naoe, Tomok 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 183 KB

Discovery and development of the complem

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

✍ Rother, Russell P; Rollins, Scott A; Mojcik, Christopher F; Brodsky, Robert A; B 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 680 KB

Erratum: Discovery and development of th

Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

✍ Rother, Russell P; Rollins, Scott A; Mojcik, Christopher F; Brodsky, Robert A; B 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

Successful liver transplantation for Bud

Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab

✍ Andrew L. Singer; Jamye E. Locke; Zoe A. Stewart; Bonnie E. Lonze; James P. Hami 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hemolytic anemia caused by somatic mutations in the phosphatidylinositol glycan-complementation class A gene and the resulting absence of a key complement regulatory protein, CD59. Affected red blood cells in patients with PNH undergo int

Treatment of paroxysmal nocturnal hemogl

Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab

✍ Alexander Röth; Ulrich Dührsen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB